Formulation Development and Evaluation of Chronomodulated Drug Delivery Systems for treatment of Diabetes
DOI:
https://doi.org/10.63682/jns.v14i19S.4772Keywords:
Chronomodulated drug delivery system, Antidiabetic drug, Glycemic control, Circadian rhythm, microspheresAbstract
The research focuses on the formulation development and evaluation of chronomodulated drug delivery systems for anti diabetic drugs, leveraging insights from past studies to optimize the delivery of Vildagliptin microspheres. Chronomodulated drug delivery systems are designed to synchronize the release of medication with the body's natural biological rhythms, enhancing therapeutic efficacy and patient compliance. Vildagliptin microspheres were meticulously prepared using an emulsion solvent evaporation method, guided by previous findings on drug-polymer ratios, surfactant concentrations, and stirring speeds to achieve optimal particle size and drug entrapment efficiency. The microspheres exhibited controlled release properties, essential for maintaining consistent drug levels in alignment with circadian rhythms. Characterization through techniques such as scanning electron microscopy (SEM), differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FTIR) confirmed the structural integrity and compatibility of the formulated microspheres. The in vitro release studies demonstrated a non-Fickian, zero-order drug release pattern, highlighting the system's potential to deliver Vildagliptin effectively over a prolonged period. The results suggest that the developed Vildagliptin loaded microspheres pulsincap system hold promise for improving the management of diabetes through a chronomodulated approach, warranting further investigation through in vivo studies to establish clinical efficacy and safety.
Downloads
Metrics
References
Greg Guthrie,Neil Poulter.; Chronotherapy in hypertension: the devil is in the details. European Heart Journal.; 2020; 41(16): 1606–1607.
Wang C, Zhang J, Liu X, Li C, Ye Z, Peng H.; Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease. PLoS One.; 2013; 8(2):55419.
Morris CJ, Purvis TE, Mistretta J, Hu K, Scheer FA.; Circadian misalignment increases C-reactive protein and blood pressure in chronic shift workers. J of biol Rhythms.; 2017;32(2): 154–64.
Mathieu C, Degrande E. Vildagliptin: a new oral treatment for type 2 diabetes mellitus. Vasc Health Risk Manag. 2008;4(6):1349-60. doi: 10.2147/vhrm.s3005. PMID: 19337548; PMCID: PMC2663430.
Ahrén B, Schweizer A, Dejager S, Villhauer EB, Dunning BE, Foley JE. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans. Diabetes Obes Metab. 2011 Sep;13(9):775-83. doi: 10.1111/j.1463-1326.2011.01414.x. PMID: 21507182.
Siddhita Tiwari, Paranjeet Kaur, Deepali Gupta, Saumik Chaudhury, Manish Chaudhary, Amit Mittal, Shubham Kumar, Sanjeev Kumar Sahu, An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets, Endocrine, Metabolic & Immune Disorders - Drug Targets, 10.2174/1871530323666230522112758, 24, 1, (50-85), (2024).
Abdelrahman M.Allam, Shereen Hassan Boltia, Azza Aziz M.Moustafa, Sally El-Mosallamy, Optimization and Evaluation of Potentiometric Sensing Membranes for Vildagliptin Determination: A Sustainable Approach Incorporating Whiteness and Greenness Assessment, Journal of The Electrochemical Society, 10.1149/1945-7111/ad6a96, (2024).
GR Sridhar, Kaushik Pandit, Sona Warrier, Ashish Birla, Sustained-Release Vildagliptin 100 mg in Type 2 Diabetes Mellitus: A Review, Cureus, 10.7759/cureus.39204, (2023).
Gupta, S. K., & Patra, S. (2024). Development, Characterization And Pharmacokinetic Evaluation Of Optimized Vildagliptin Sustained Release Matrix Tablet Using Box-behnken Design. International Journal Of Applied Pharmaceutics, 16(1), 214–233. https://Doi.Org/10.22159/Ijap.2024v16i1.48052.
Ammanage, A. S., & Mastiholimath, V. S. (2023). A Systematic Approach to Vildagliptin-Eudragit RL 100 Coated Nanoparticles by Combined Techniques of Solvent Evaporation and Nano-precipitation Using Quality by Design Concept. International Journal of Pharmaceutical Investigation, 14(1), 250–25.7.
Merir Roufaida, Baitiche Milad.; Conception of Cellulose Aligi/Mesalazine microspheres by solvent evaporation technique for drug release: Experimental and theoretical investigations.; 20
Kurapati, p., & Chinni, s. (2024). Development and optimization of rabeprazole chrono-modulated drug delivery systems. International journal of applied Pharmaceutics, 16(3), 332–341.
Prasanthi1 R, Haarika B , Selvamuthukumar S , Design Formulation and Statistical Evaluation of Gastroretentive Microspheres of Rasagiline Mesylate for Parkinson’s Disease Using Design Expert. Indian Journal of Pharmaceutical Education and Research, Vol 57, Issue 2(Suppl), Apr-Jun, 2023.
Agam T, Yadav G, Jain A, Ware P, Kamble S. Formulation and Evaluation of Pulsatile Drug Delivery System of Dexlansoprazole. Scopus Indexed. 2023 Sep. 15 [cited 2024 Jul. 9];16(5):6976-8.
Kumari Beena, Khansili Aparna.; Development and optimization of vildagliptin loaded floating microspheres using central composite design: in vitro and in vivo evaluation:Annals of the Romanian Society
Pande R, Selvamurthy W.; Design and In Vitro Characterization of Novel Pulsatile Delivery System of Biguanide Antidiabetic Drug. Journal of Pharmacy and Bioallied Sciences.; 2020;12(3): 356-368.
Ss. Prasanna Kumar And L. Srinivas , A review on pulsatile drug delivery systems , International journal of pharmaceutical sciences and research , 2023; Vol. 14(7): 3246-3254
Ciancia S, Caferelli, A.; Pulsatile Drug Delivery System Triggered by Acoustic Radiation Force. NCBI. 2020; (8): 313.
Malakar, A., & Bokshi, B. Formulation and Evaluation of Allylestrenol Immediate Release Tablets. 2012.
Patil S. Pund S. Joshi. Chronomodulated press coated pulsatile therapeutic system for aceclofenac: Optimization of factors influencing drug release and lag time. ChronoPhysiology and Therapy. 2011 1. 1-10. 10.2147/CPT.S16504.
Pharmaceutical Experiments Using Design Expert ® Software,” Gulf Medical University, Feb. 21, 2019.https://gmu.ac.ae/cop_news/pharmaceutical-experiments-using-design-expert-software.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
